The Recall Desk
ModerateFDA (Devices)·Z-1385-2014·Announced 2014-04-16

LumiQuick Morphine Test Card Recalled for Unapproved Distribution

LumiQuick Diagnostics Inc. is recalling Morphine Test Cards because they were shipped to US locations without required FDA approvals.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity score when no specific physical hazards or injuries are reported, and the issue is primarily regulatory compliance.

Plain-English summary

LumiQuick Diagnostics Inc. is recalling Morphine Test Cards (Catalog number 74030, all lots) because the products were shipped to US locations that do not have approved applications for PMA, IDE, or 510(k) clearance. The recall affects all units of this product.

The products were distributed in the states of California, Florida, New Jersey, Texas, and New York. The recall is due to regulatory non-compliance regarding the distribution of medical devices without the necessary FDA clearances or approvals.

Consumers and healthcare providers who have received these products should stop using them and contact the recalling firm for further instructions.

The recalled product

Product
Morphine Test Card (300); LumiQuick, Santa Clara, CA 95054

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Catalog number: 74030
  • All lots

Distribution

Distributed in 5 states:

Part of a larger recall action

This product is one of 80 recalled by LumiQuick Diagnostics Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 80 products in this recall →

Same manufacturer · LumiQuick Diagnostics Inc.

See all →